Matthew Chan - Concepedia

Author

Matthew Chan

The University of Sydney ORCID

Also Known As

M Chan, M. Chan, M. M. K. Chan, M.M. Chan, M.M.K. Chan, Matthew Chan, Matthew M. K. Chan, Matthew MK Chan

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

The University of Sydney Melanoma Institute Australia Westmead Hospital BC Cancer Agency University of British Columbia

About

Matthew Chan is an author at The University of Sydney specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	9	232
2	Health Sciences	2	2	59
3	Cell Biology	1	1	11
4	Gastroenterology	1	1	18
5	Geriatrics	1	1	18

Matthew Chan

Publications

941

Citations

H-Index

Page 1

	Year	Citations
RETRACTED ARTICLE: sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance Amanpreet Kaur, Marie R. Webster, Katie Marchbank, Nature	2016	386
The nature and management of metastatic melanoma after progression on <scp>BRAF</scp> inhibitors: Effects of extended <scp>BRAF</scp> inhibition Matthew Chan, Lauren E. Haydu, Alexander M. Menzies, Cancer	2014	72
Targeting Primitive Chronic Myeloid Leukemia Cells by Effective Inhibition of a New AHI-1–BCR-ABL–JAK2 Complex Min Chen, Paolo Gallipoli, Donna DeGeer, JNCI Journal of the National Cancer Institute	2013	72
IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia Shawn J. Kile, William Au, Carol Parise, Journal of Neurology Neurosurgery & Psychiatry	2015	72
Association Between Palliative Resection of the Primary Tumor and Overall Survival in a Population-Based Cohort of Metastatic Colorectal Cancer Patients Gillian Gresham, Daniel J. Renouf, Matthew Chan, Annals of Surgical Oncology Surgical OncologyOverall SurvivalGastrointestinal OncologyMedicinePopulation-based Cohort	2014	52
Clinicopathologic features associated with efficacy and long‐term survival in metastatic melanoma patients treated with <scp>BRAF</scp> or combined <scp>BRAF</scp> and MEK inhibitors Alexander M. Menzies, James S. Wilmott, Martin Drummond, Cancer	2015	49
Metastasis‐specific patterns of response and progression with anti‐<scp>PD</scp>‐1 treatment in metastatic melanoma Jenny Lee, Megan Lyle, Alexander M. Menzies, Pigment Cell & Melanoma Research	2017	44
Symptomatic Histologically Proven Necrosis of Brain following Stereotactic Radiation and Ipilimumab in Six Lesions in Four Melanoma Patients Stephanie Du Four, Angela Hong, Matthew Chan, Case Reports in Oncological Medicine Surgical OncologyFour Melanoma PatientsPathologyBrain LesionNeuro-oncology	2014	38
Ipilimumab‐induced hypophysitis in melanoma patients: an <scp>A</scp>ustralian case series Teresa Lam, Matthew Chan, Arianne Sweeting, Internal Medicine Journal	2015	36
A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial Andrew R. Davidson, A.-S. Veillard, Annette Tognela, Annals of Oncology Topical NitroglycerinMedicinePhase IiiPharmacologyClinical Trials	2015	33

Page 1